Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$4.8B
118M shares
52-week range
$19.31 – $42.81
89% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
www.indivior.comNo one on the platform currently holds INDV.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 37,141 | $1.1M |
No one on the platform has traded INDV yet.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.3B | +5.8% | $3.73 | $3.65–$3.80 | 10.8× | 2 |
| 2027 | $1.3B | +4.2% | $4.03 | $3.95–$4.11 | 10.0× | 3 |
| 2028 | $1.4B | +4.7% | $4.17 | $3.73–$4.62 | 9.6× | 2 |
| 2029 | $1.4B | +5.2% | $4.27 | $4.18–$4.36 | 9.4× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-30 | $0.64 | $0.96 | +50.0% |
| 2026-02-26 | $0.65 | $0.82 | +26.2% |
| 2025-10-30 | $0.38 | $0.72 | +89.5% |
| 2025-07-31 | $0.26 | $0.51 | +96.2% |
| 2025-04-24 | $0.22 | $0.41 | +86.4% |
| 2025-02-20 | $0.32 | $0.32 | +0.0% |
| 2024-10-24 | $0.31 | $0.54 | +74.2% |
| 2024-07-25 | $0.40 |
| $0.44 |
| +10.0% |
| -0.30% |
| $8.9B |
| — |
| HNGEHinge Health, Inc. | $75.11 | +1.42% | $5.8B | — |
| LNTHLantheus Holdings, Inc. | $101.00 | +1.00% | $6.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Hugging the line! $INDV tests the 21-EMA as the next move takes shape Indivior ($INDV) finished at $40.54. The stock absorbed recent healthcare sector rotation and continues building a base while holding near its key short-term trend line. This is a classic 21-EMA continuation setup. Bulls need volume confirmation to push price above the current consolidation zone and trigger a possible momentum breakout. If the breakout takes longer, the previous horizontal support area remains the key accumulation zone. The chart is showing patience, not weakness. The next reaction from this level could define the short-term trend. Charts tell the story before headlines do.
View on StockTwits ↗$INDV I made an entry to invest how I can into suboxone From my understanding it will help people get off the gas station heroin which is supposed to be banned soon 🤷♂️ I pray for anyone addicted to drugs
View on StockTwits ↗$INDV | Barclays Starts Indivior at Overweight with $46 PT on EBITDA Growth and Sublocade Momentum Barclays stays bullish as management execution, cost optimization, and mid-teens Sublocade growth support long-term upside. 🔹 Follow @tenet_research for more analyst insights on other tickers.
View on StockTwits ↗$INDV Share Price: $37.65 Contract Selected: Nov 20, 2026 $40 Calls Buy Zone: $2.72 – $3.36 Target Zone: $4.73 – $5.78 Potential Upside: 64% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$INDV Outstanding article that hits the mark on INDV's current state. So if you want to refresh your INDV insights or learn about INDV from scratch, this is a must read. https://everyticker.com/quote/INDV/analysis/indivior-s-sublocade-transformation-margin-inflection-meets-patent-protected-growth-nasdaq-indv
View on StockTwits ↗Indivior PLC shares rose Monday after the company announced a $175 million accelerated share repurchase (ASR) agreement with Barclays Bank PLC. The ASR is part of Indivior’s previously authorized $400 million buyback program and reflects confidence in its long-term strategy, cash flow generation, and disciplined capital allocation. Under the deal, Indivior will make an upfront $175 million payment and expects to receive an initial delivery of 3,717,473 shares. The final number of shares will depend on the volume-weighted average price during the ASR period, minus a discount. Final settlement is expected by the end of June 2026. The company said the ASR will not impact its previously issued financial guidance. The remaining $100 million under the buyback authorization may be used for additional repurchases depending on market conditions. $INDV
View on StockTwits ↗$INDV (+2.9% pre) Indivior launches $175M accelerated share buyback https://ooc.bz/l/100901
View on StockTwits ↗$INDV (+8.4% pre) Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance https://ooc.bz/l/100560
View on StockTwits ↗$INDV $4 billion FEW followers the best trends … this one biotech
View on StockTwits ↗$INDV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $3.55 up 86.84% YoY • Reported revenue of $317M up 19.17% YoY • Indivior raised its full-year 2026 financial guidance, now expecting 2026 total SUBLOCADE net revenue growth of 13% year-over-year and adjusted EBITDA growth of 50% year-over-year at the midpoint of its ranges.
View on StockTwits ↗$INDV great company great product but takes so long to find a bottom after ipo. Was holding for months at 15$ but assumed market was priced correctly if it was that low for that long
View on StockTwits ↗$INDV 10/30 gap still controls the pattern. chop chop da huckleberries are below da YUGE $$$ for another eps gap n go thru da $$$ ONTO 🐒🍌🧠⏰♾️. 🖕opioids.
View on StockTwits ↗$INDV (-5.8% pre) Indivior stock falls after convertible notes offering announced https://ooc.bz/l/96495
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.